Growth Metrics

Edwards Lifesciences (EW) Operating Expenses (2016 - 2025)

Edwards Lifesciences has reported Operating Expenses over the past 17 years, most recently at $766.9 million for Q4 2025.

  • Quarterly results put Operating Expenses at $766.9 million for Q4 2025, up 0.7% from a year ago — trailing twelve months through Dec 2025 was $3.1 billion (up 6.47% YoY), and the annual figure for FY2025 was $3.2 billion, up 10.23%.
  • Operating Expenses for Q4 2025 was $766.9 million at Edwards Lifesciences, down from $795.4 million in the prior quarter.
  • Over the last five years, Operating Expenses for EW hit a ceiling of $862.2 million in Q4 2023 and a floor of $336.6 million in Q4 2022.
  • Median Operating Expenses over the past 5 years was $700.8 million (2024), compared with a mean of $668.8 million.
  • Biggest five-year swings in Operating Expenses: dropped 27.0% in 2021 and later soared 156.15% in 2023.
  • Edwards Lifesciences' Operating Expenses stood at $431.1 million in 2021, then fell by 21.92% to $336.6 million in 2022, then soared by 156.15% to $862.2 million in 2023, then decreased by 11.67% to $761.6 million in 2024, then rose by 0.7% to $766.9 million in 2025.
  • The last three reported values for Operating Expenses were $766.9 million (Q4 2025), $795.4 million (Q3 2025), and $782.4 million (Q2 2025) per Business Quant data.